20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shattuck Labs Inc (STTK) operates in the BIOTECHNOLOGY industry and is headquartered in Austin, United States with about 40 employees. Its market capitalization is roughly $549 million. In the fiscal year ended 2025-12-31, STTK reported $1M in revenue and ($49M) in net income.
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States.
Interactive charts & full statements → Open the STTK valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $6M | $2M | $1M | $30M | $10M | $10M | $22M |
| Gross Profit | — | ($2M) | $1M | ($2M) | $1M | $29M | $10M | ($19M) | ($2M) |
| Gross Margin % | — | -195.1% | 14.5% | -143.9% | 100.0% | 95.4% | 100.0% | -195.5% | -10.5% |
| Operating Income (EBIT) | ($56M) | ($52M) | ($81M) | ($92M) | ($103M) | ($45M) | ($37M) | ($25M) | ($6M) |
| Operating Margin % | -5578.7% | -5150.8% | -1408.3% | -5549.6% | -15848.0% | -150.8% | -371.8% | -253.5% | -27.4% |
| Net Income | ($53M) | ($49M) | ($75M) | ($87M) | ($101M) | ($45M) | ($35M) | ($24M) | ($7M) |
| Net Margin % | -5256.8% | -4880.9% | -1318.1% | -5268.4% | -15423.5% | -149.8% | -356.7% | -242.6% | -32.9% |
| EBITDA | ($48M) | ($45M) | ($72M) | ($83M) | ($100M) | ($44M) | ($36M) | ($25M) | ($5M) |
| Earnings Per Share (EPS) | $-0.51 | $-0.70 | $-1.49 | $-2.05 | $-2.37 | $-1.07 | $-0.85 | $-0.57 | $-0.49 |
| Shares Outstanding (M) | 130M | 70M | 51M | 43M | 42M | 42M | 42M | 42M | 15M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | $0M | $14M | $35M | $3M |
| Gross Profit | — | ($1M) | ($1M) | ($7M) | ($1M) | ($1M) | $14M | $2M |
| Gross Margin % | — | — | — | -661.8% | — | -6.5% | 41.8% | 68.2% |
| Operating Income (EBIT) | ($16M) | ($16M) | ($13M) | ($11M) | ($13M) | ($14M) | ($20M) | ($18M) |
| Operating Margin % | — | — | — | -1071.6% | — | -99.3% | -56.6% | -597.9% |
| Net Income | ($15M) | ($15M) | ($13M) | ($10M) | ($12M) | ($14M) | ($19M) | ($17M) |
| Net Margin % | — | — | — | -1005.6% | — | -94.5% | -53.8% | -556.4% |
| EBITDA | ($14M) | ($14M) | ($12M) | ($9M) | ($12M) | ($13M) | ($18M) | ($16M) |
| Earnings Per Share (EPS) | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 |
| Shares Outstanding (M) | 130M | 112M | 104M | 72M | 51M | 51M | 51M | 51M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($41M) | ($40M) | ($61M) | ($81M) | ($94M) | ($57M) | ($34M) | ($21M) | ($7M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $12M | $8M | $1M | $0M | $1M |
| Free Cash Flow (FCF) | ($41M) | ($40M) | ($61M) | ($82M) | ($106M) | ($65M) | ($34M) | ($21M) | ($8M) |
| FCF Margin % | -4130.3% | -3995.3% | -1058.8% | -4926.7% | -16274.9% | -216.7% | -346.1% | -216.9% | -36.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($10M) | ($13M) | ($8M) | ($9M) | ($10M) | ($12M) | ($17M) | ($16M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $10M | $12M | $0M | $0M |
| Free Cash Flow (FCF) | ($10M) | ($13M) | ($8M) | ($9M) | ($21M) | ($24M) | ($17M) | ($16M) |
| FCF Margin % | — | — | — | -900.0% | — | -166.1% | -50.0% | -537.5% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $221M | $91M | $91M | $160M | $205M | $299M | $349M | $45M | $68M |
| Cash & Cash Equivalents | $63M | $54M | $57M | $126M | $47M | $92M | $158M | $7M | $32M |
| Total Liabilities | $10M | $9M | $11M | $15M | $29M | $27M | $39M | $80M | $79M |
| Total Debt (Short + Long-Term) | $1M | $1M | $1M | $1M | $1M | $0M | $7M | $4M | $2M |
| Total Shareholders' Equity | $211M | $82M | $80M | $145M | $176M | $272M | $310M | ($35M) | ($11M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STTK viewer.
About TickerBase · Data methodology & sources · Privacy · Terms